We use cookies to support your experience on our website. Further details, including advice on disabling cookies, are available in our privacy and cookies policy.Close
Since an initial 11 signatories were announced in late June – including Cambridge University Press, Elsevier and Oxford University Press – eight further signatories are announced today, including SAGE, eLife and Wiley.
In this highlights piece we cover extracts from our Editor Viewpoints series. In these extracts, editors from across our journals share their thoughts on the COVID-19 pandemic, and how they expect the crisis to change the way we do research in the future.
Cutting edge chemical science technology and computer-aided drug design (CADD) is bringing together leading minds from across the world to help tackle the COVID-19 crisis.
We are marking this milestone by recognising 10 years of high quality, accessible research from across the globe. A gold open access flagship journal, Chemical Science is built on a multidisciplinary research community and has been free to read and free to publish for the last five years.
